Levetiracetam Hexal

Levetiracetam, the active ingredient in Levetiracetam Hexal, is an anticonvulsant presented as a tablet for oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. - Partial seizures: helps control focal onset seizures and reduces their frequency. - Generalized tonic‑clonic seizures: provides seizure freedom or reduction in patients with primary generalized epilepsy. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: general feeling of tiredness. - Somnolence: increased sleepiness. - Headache: mild to moderate cranial pain. - Irritability: mood changes or agitation. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe skin reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence of depressive ideation or self‑harm urges. - Severe depression: marked mood disturbances requiring medical attention. - Blood disorders: such as neutropenia or thrombocytopenia. - Hypersensitivity: anaphylaxis or angioedema. - Multi‑organ involvement: rare cases of hepatic or renal dysfunction.

Before initiating therapy, clinicians should consider several safety aspects. - Renal impairment: adjust dose based on creatinine clearance. - Mood monitoring: watch for depression, anxiety, or suicidal ideation. - Discontinuation: avoid abrupt cessation to prevent seizure worsening. - Elderly patients: start at lower dose and titrate cautiously. - Pregnancy: safety category unknown; weigh benefits against potential risks. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam has a relatively low interaction profile, but certain combinations require attention.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., carbamazepine, phenytoin, phenobarbital): may reduce levetiracetam plasma levels. - Concomitant use with other antiepileptics that lower seizure threshold: could diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): may increase sedation. - NSAIDs: possible increase in adverse gastrointestinal effects. - Antidepressants: monitor for additive mood changes. - Immunosuppressants: observe for altered immune response.